COCH
Envoy Medical, Inc.Company Information
- Company Name
- Envoy Medical, Inc.
- CIK
- CIK0001840877
- Category
- <br>Emerging growth company
- Ticker: Exchange
- COCH: Nasdaq, COCHW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3842
- SIC Description
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Ticker
- COCH
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-02-12
- Last sale
- —
- Shares purchased (TTM)
- 20,481,150
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 17,729,960
- Shares outstanding
- 104,039,109
- Ownership
- 17.04%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- 0.71%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Related Party | -0 | 1 | 1 | 0 | -0 | 1 | 1 | -0 | 1 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 20 | 25 | 4 | 4 | 5 | 5 | 5 | 4 | 2 | 5 | 4 | 7 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | - | - | - | - | 5 | ||||||
| Other Restricted Assets | - | - | - | - | - | - | - | - | - | - | - | 4 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | ||||||
| Inventory Net | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Cash | - | - | 4 | - | - | - | 5 | - | 2 | 5 | 4 | - | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | ||||||
| Assets Current | 22 | 28 | 6 | 6 | 8 | 8 | 9 | 7 | 5 | 8 | 7 | 20 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Noncurrent | - | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets | 0 | 0 | 0 | - | 0 | - | 0 | - | - | - | - | - | ||||||
| Assets | 24 | 30 | 9 | 8 | 10 | 10 | 12 | 9 | 7 | 8 | 8 | 21 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 3 | ||||||
| Accrued Liabilities Current | 10 | 10 | 8 | 6 | 5 | 5 | 4 | 7 | 6 | 6 | 5 | 4 | ||||||
| Warrants And Rights Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Product Warranty Accrual Classified Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Other Liabilities Current | 0 | 0 | 1 | 0 | 0 | 0 | 1 | - | - | - | 1 | - | ||||||
| Liabilities Current | 13 | 12 | 12 | 9 | 8 | 8 | 8 | 9 | 8 | 7 | 7 | 13 | ||||||
| Product Warranty Accrual Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - | 2 | - | ||||||
| Derivative Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 1 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 1 | 1 | 1 | 1 | - | - | - | - | - | ||||||
| Liabilities | 20 | 19 | 20 | 16 | 40 | 35 | 30 | 28 | 19 | 16 | 10 | 16 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Additional Paid In Capital | 330 | 329 | 301 | 298 | 268 | 267 | 266 | 259 | 258 | 258 | 256 | 256 | ||||||
| Retained Earnings Accumulated Deficit | -326 | -319 | -313 | -306 | -298 | -291 | -285 | -278 | -270 | -265 | -257 | -251 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Stockholders Equity | 3 | 10 | -12 | -8 | -30 | -24 | -19 | -19 | -12 | -7 | -2 | 5 | ||||||
| Liabilities And Stockholders Equity | 24 | 30 | 9 | 8 | 10 | 10 | 12 | 9 | 7 | 8 | 8 | 21 | ||||||
| Series A Preferred Stock | 2 | 0 | 0 | -4 | 0 | 4 | 0 | 0 | -4 | 0 | 0 | 0 | ||||||
| Common Class A | 27 | 0 | 0 | -1 | -21 | 21 | 0 | 0 | -19 | 0 | 0 | -0 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | 4 | 4 | - | - | 100 | 100 | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | - | 0.01 | ||||||
| Preferred Stock Shares Authorized | - | - | - | 100 | 100 | 100 | 10 | 100 | - | - | 10 | - | ||||||
| Preferred Stock Shares Outstanding | - | - | - | 4 | 4 | 4 | - | - | - | - | 5 | 5 | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | - | - | 0.00 | 0.00 | - | - | - | - | - | - | ||||||
| Common Stock Shares Authorized | - | - | - | - | 400 | 400 | - | - | - | - | - | - | ||||||
| Common Stock Shares Issued | - | - | - | - | 22 | 21 | - | - | - | - | - | - | ||||||
| Shares Outstanding | - | - | - | - | 22 | 21 | - | 19 | 19 | - | 20 | 20 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEnvoy Medical, Inc. (COCH) — SEC Financial Statements & Analysis
Envoy Medical, Inc. (COCH) is a orthopedic, prosthetic & surgical appliances & supplies company. Envoy Medical, Inc. trades on Nasdaq as: COCH, COCHW. Envoy Medical, Inc. (COCH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, Envoy Medical, Inc. carries a market cap of $82.40M, a P/E ratio of -2.66x, a P/B ratio of 24.95x, a P/S ratio of 398.06x, an enterprise value of $62.72M, and an EV/EBITDA multiple of -2.69x. On profitability, it posts a gross margin of -385.51%, an operating margin of -11411.11%, a net margin of -14950.24%, a Return on Equity (ROE) of 233.07%, and a Return on Assets (ROA) of -182.85%. Per share, it reports EPS of $-0.30, diluted EPS of $-0.30, free cash flow per share of $-0.21, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -6.76% year-over-year, net income growth of 14.28% year-over-year, and EPS growth of -76.51% year-over-year. On the balance sheet, it maintains a current ratio of 1.73x, a quick ratio of 1.56x, working capital of $9.28M, a debt-to-equity ratio of 6.13x, a debt ratio of 0.85, an interest coverage ratio of -50.15x, free cash flow of $-21.71M (TTM), and net debt of $-19.68M. Figures sourced from SEC EDGAR.
- Market Cap
- $82.40M
- P/E TTM
- -2.66x
- EPS TTM
- $-0.30
- P/B TTM
- 24.95x
- ROE TTM
- 233.07%
- ROA TTM
- -182.85%
- Debt To Equity
- 6.13x
- Free Cash Flow TTM
- $-21.71M
- Net Revenue TTM Growth 1Y
- -6.76%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Envoy Medical, Inc. in?
Envoy Medical, Inc. (COCH) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
What exchange does COCH trade on?
Envoy Medical, Inc. (COCH) trades on the Nasdaq.
When was Envoy Medical, Inc. (COCH)'s most recent SEC filing?
Envoy Medical, Inc. (COCH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is COCH's market cap?
Envoy Medical, Inc. (COCH) has a market capitalization of $82.40M as of 2026-06-30.
What is COCH's EPS (earnings per share)?
Envoy Medical, Inc. (COCH)'s trailing twelve month EPS is $-0.30 as of 2026-06-30.
What is COCH's ROE (return on equity)?
Envoy Medical, Inc. (COCH)'s trailing twelve month Return on Equity (ROE) is 233.07% as of 2026-06-30.
What is COCH's ROA (return on assets)?
Envoy Medical, Inc. (COCH)'s trailing twelve month Return on Assets (ROA) is -182.85% as of 2026-06-30.
What is COCH's EV/EBITDA?
Envoy Medical, Inc. (COCH)'s trailing twelve month EV/EBITDA is -2.69x as of 2026-06-30.